José Brea - Concepedia

Author

José Brea

Universidade de Santiago de Compostela ORCID

Also Known As

Boyom, Fabrice F, Brea, J.M., Brea, Jose, Brea, José, Brea, José M., J BREA, J Brea, J M Brea, J. Brea, J.M. Brea

260

Publications

4.8K

Citations

H-Index

124

Concepts

All Affiliations

Universidade de Santiago de Compostela Center for Research in Molecular Medicine and Chronic Diseases Universitat de Barcelona Universitat Pompeu Fabra Uppsala University

About

José Brea is an author at Universidade de Santiago de Compostela specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	60	2.4K
2	Natural Sciences	13	16	961
3	Engineering	8	8	444
4	Social Sciences	4	4	79
5	Health Sciences	2	2	54

José Brea

128

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond Wesley C. Van Voorhis, John H. Adams, Roberto Adelfio, PLoS Pathogens Drug TargetBioorganic ChemistryAntiparasitic AgentMalariaMedicinal Chemistry	2016	441
Chitosan–hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma Felipe Oyarzún-Ampuero, José Brea, Marı́a Isabel Loza, International Journal of Pharmaceutics AsthmaNanomedicineNanoparticlesEngineeringAllergy	2009	215
Matching Recall and Storage in Sequence Learning with Spiking Neural Networks José Brea, Walter Senn, Jean-Pascal Pfister Journal of Neuroscience	2013	136
Identification of New Activators of Mitochondrial Fusion Reveals a Link between Mitochondrial Morphology and Pyrimidine Metabolism Laia Miret‐Casals, David Sebastián, José Brea, Cell chemical biology Membrane FusionMitochondrial FunctionBiochemistryPyrimidine MetabolismMedicine	2017	132
Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13 Laura Jenkins, José Brea, Nicola J. Smith, Biochemical Journal Novel Species-selective AgonistsActivate Gα13PharmacotherapyG-protein-coupled Receptor Gpr35Experimental Pharmacology	2010	105
Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics María Barceló, Enrique Raviña, Christian F. Masaguer, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicinePsychotropic MedicationNew PyrazolePsychopharmacology	2007	78
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease Christian Griñán‐Ferré, Sandra Codony, Eugènia Pujol, Neurotherapeutics Soluble Epoxide HydrolaseAlzheimer's DiseaseBiochemistryMedicineDementia	2020	78
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model Miriam Redondo, Juan G. Zarruk, Plácido A. Ceballos, European Journal of Medicinal Chemistry Cerebral Vascular RegulationIschemic StrokeStrokeMedicineNeuroprotective Efficacy	2011	70
Discovery of 3,4-Dihydropyrimidin-2(1<i>H</i>)-ones As a Novel Class of Potent and Selective A<sub>2B</sub>Adenosine Receptor Antagonists Abel Crespo, Abdelaziz El Maatougui, Pierfrancesco Biagini, ACS Medicinal Chemistry Letters	2013	67
Structure-Based Discovery of Selective Serotonin 5-HT 1B Receptor Ligands David Rodríguez, José Brea, Marı́a Isabel Loza, Structure Drug TargetFunctional SelectivityMedicineReceptor LigandsReceptor (Biochemistry)	2014	61

Page 1